February 23, 2023 01:55 PM ESTUpdated February 24, 08:43 AM

Bristol Myers expands footprint in India with drug development and IT center

Katherine Lewin

News Reporter

Pharma giant Bristol Myers Squibb will expand its footprint in Hyderabad, India, with a life sciences hub that will focus on IT and drug development …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Bristol Myers expands footprint in India with drug development and IT center

Katherine Lewin

News Reporter

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer

RFK Jr. defends HHS staff cuts, reorganization plans in House, Senate hearings

AbbVie doubles down on siRNA with $335M upfront bet on ADARx

RFK Jr. says his opinions of vaccines are ‘irrelevant.’ Former FDA chief Califf disagrees

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B

Bris­tol My­ers ex­pands foot­print in In­dia with drug de­vel­op­ment and IT cen­ter

News Reporter

Sign up to read this article for free.

more like this

Celldex Therapeutics

Hampton, NJ, USA

Bristol Myers expands footprint in India with drug development and IT center